BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1730124)

  • 21. Intracavitary use of radioactive colloidal phosphorus 32 in the treatment of epithelial ovarian cancer.
    Saul HM; Sedlacek TV; Heller PB; Glassburn JR; Riva J; Bertoli R; Maslack M; Lin JK
    J Am Osteopath Assoc; 1996 Dec; 96(12):727-32. PubMed ID: 9111774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
    Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
    Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; GĂ©rard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
    Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
    J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy.
    Bolis G; Zanaboni F; Vanoli P; Russo A; Franchi M; Scarfone G; Pecorelli S
    Gynecol Oncol; 1990 Nov; 39(2):150-4. PubMed ID: 2227589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
    Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of P-32 in stage III epithelial carcinoma of the ovary.
    Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
    Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
    Tarraza HM; Boyce CR; Smith WG; Jones MA
    Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary cytoreduction in epithelial ovarian cancer.
    Morgan MA; Rubin SC
    Crit Rev Oncol Hematol; 1995 Jan; 18(1):1-8. PubMed ID: 7695822
    [No Abstract]   [Full Text] [Related]  

  • 33. Radiotherapy in early ovarian cancer.
    Thomas GM
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S73-9. PubMed ID: 7835813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postoperative adjuvant whole abdomen irradiation in ovarian cancer].
    Lindner H; Willich N; Atzinger A; Schubert-Fritschle G
    Onkologie; 1990 Aug; 13(4):260-7. PubMed ID: 2234778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
    Jones E; Alvarez Secord A; Prosnitz LR; Samulski TV; Oleson JR; Berchuck A; Clarke-Pearson D; Soper J; Dewhirst MW; Vujaskovic Z
    Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
    Soper JT; Berchuck A; Clarke-Pearson DL
    Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I; Nordqvist S; Sorbe B
    Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
    Piccart MJ; Bertelsen K; James K; Cassidy J; Mangioni C; Simonsen E; Stuart G; Kaye S; Vergote I; Blom R; Grimshaw R; Atkinson RJ; Swenerton KD; Trope C; Nardi M; Kaern J; Tumolo S; Timmers P; Roy JA; Lhoas F; Lindvall B; Bacon M; Birt A; Andersen JE; Zee B; Paul J; Baron B; Pecorelli S
    J Natl Cancer Inst; 2000 May; 92(9):699-708. PubMed ID: 10793106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adjuvant radioactive gold therapy of primary stage I c ovarian cancer].
    Schwarz R; Schumacher A
    Zentralbl Gynakol; 1989; 111(23):1538-41. PubMed ID: 2560301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.